In the US, Cetuximab (cetuximab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer and Squamous Cell Carcinoma.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Monoclonal antibody against epidermal growth factor receptor
Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer (WHO)
- Cetuximabum (Latin)
- Cetuximab (German)
- Cétuximab (French)
- Cetuximab (Spanish)
- Cetuximab (OS: USAN)
- Cetuximab (Genetical Recombination) (OS: JAN)
- C 225 (IS: ImClone)
- IMC-C 225 (IS: ImClone)
Boehringer Ingelheim, China; Bristol-Myers Squibb, Canada; Haemato Pharm, Austria; Healthcare Logistics, New Zealand; ImClone, United States; Merck, Austria; Merck, Belgium; Merck, Switzerland; Merck, Czech Republic; Merck, Ecuador; Merck, Egypt; Merck, Finland; Merck, Georgia; Merck, Greece; Merck, Hong Kong; Merck, Croatia (Hrvatska); Merck, Hungary; Merck, Indonesia; Merck, Israel; Merck, Iceland; Merck, South Korea; Merck, Lithuania; Merck, Mexico; Merck, Malaysia; Merck, Philippines; Merck, Poland; Merck, Serbia; Merck, Sweden; Merck, Slovakia; Merck, Thailand; Merck, Tunisia; Merck, Venezuela; Merck KGAA, Cyprus; Merck Pharma, Italy; Merck S.L., Spain; Merck Serono, Argentina; Merck Serono, Australia; Merck Serono, China; Merck Serono, Germany; Merck Serono, Denmark; Merck Serono, France; Merck Serono, United Kingdom; Merck Serono, Ireland; Merck Serono, Japan; Merck Serono, Norway; Merck Serono, Oman; Merck Serono, Taiwan; Merck Serono, South Africa; Merck Sharp & Dohme, Bosnia & Herzegowina
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.